Modification of atherosclerosis by agents that do not lower cholesterol

作者： J. G F Cleland , D. M Krikler

关键词: Probucol 、 Medicine 、 Fibrinolytic agent 、 Endocrinology 、 Vascular disease 、 Warfarin 、 Coronary atherosclerosis 、 Cardiology 、 Aspirin 、 Internal medicine 、 Cholesterol 、 Arteriosclerosis

摘要: In patients who already have clinical evidence of coronary atherosclerosis there is now clear that several different lipid lowering agents can delay or even reverse the atherosclerotic process reducing incidence cardiovascular events and delaying mortality. 12 However, relation between blood cholesterol poor in practical terms, though a strong statistical exists